Discover
OPRX
OptimizeRx Corporation
6.08
2 x 4.35
2 x 7.39
bid
ask
+
0.36
6.29%
2 @ 06:01 AM
6.13 +0.05 (0.82%)
| Ytd | -50.41% | |
| 1y | -55.26% |
5.78
day range
6.15
4.54
52 week range
22.25
| Open | 5.80 | Prev Close | 5.72 | Low | 5.78 | High | 6.15 | Mkt Cap | 114.09M |
| Vol | 595.23K | Avg Vol | 482.56K | EPS | 0.36 | P/E | 16.89 | Forward P/E | 9.86 |
| Beta | 1.32 | Short Ratio | 2.70 | Inst. Own | 68.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 5.55 | 200-d Avg | 11.00 | 1yr Est | 10.36 |
OPRX News
benzinga.com
OptimizeRx Rolls Out CopayCue To Provide Enhanced Brand Savings For Physicians
OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology
globenewswire.com
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Pres
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP
globenewswire.com
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planni
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, veri